Abstract
The antibiotic susceptibilities of 16 clinical isolates of Aeromonas hydrophila obtained from cancer patients with septicemia were studied. Of the new beta-lactam antibiotics tested, azthreonam and moxalactam were the most active, followed by cefoperazone, cefotaxime, and ceftizoxime. Excellent activity was demonstrated by chloroamphenicol, tetracycline, aminoglycosides, and trimethoprim-sulfamethoxazole. Semisynthetic penicillins had no appreciable activity against this organism.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Davis W. A., 2nd, Kane J. G., Garagusi V. F. Human aeromonas infections: a review of the literature and a case report of endocarditis. Medicine (Baltimore) 1978 May;57(3):267–277. [PubMed] [Google Scholar]
- Fainstein V., Weaver S., Bodey G. P. Comparative in vitro study of SQ26,776. Antimicrob Agents Chemother. 1982 Feb;21(2):294–298. doi: 10.1128/aac.21.2.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fass R. J., Barnishan J. In vitro susceptibilities of Aeromonas hydrophila to 32 antimicrobial agents. Antimicrob Agents Chemother. 1981 Feb;19(2):357–358. doi: 10.1128/aac.19.2.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fass R. J. In vitro activity of cefoperazone against nonfermenters and Aeromonas hydrophila. Antimicrob Agents Chemother. 1980 Sep;18(3):483–486. doi: 10.1128/aac.18.3.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Overman T. L. Antimicrobial susceptibility of Aeromonas hydrophila. Antimicrob Agents Chemother. 1980 Apr;17(4):612–614. doi: 10.1128/aac.17.4.612. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wolff R. L., Wiseman S. L., Kitchens C. S. Aeromonas hydrophila bacteremia in ambulatory immunocompromised hosts. Am J Med. 1980 Feb;68(2):238–242. doi: 10.1016/0002-9343(80)90360-5. [DOI] [PubMed] [Google Scholar]